glp-1 drugs overview Market Overview: Agonists and the Obesity Market | Blog Harnessing GLP-1 Receptor Agonists for
Description
Cholesterol, glucose and insulin levels, liver fat, and blood pressure all appear to improve with these medications

Anticholinergic drugs should be avoided in elderly patients, patients with preexisting cognitive defects, and those with dysphagia

In addition, HA products can improve the overall appearance of wrinkles and folds in the lower face and neck

1 For patients who do not achieve their target A1C with metformin, the Diabetes Canada 2018 guidelines recommend selecting add-on therapy based on individual patient characteristics

North American Congress of Clinical Toxicology 2011

Since elevated liver enzymes can be a concerning side effect for individuals taking GLP-1 receptor agonists, liver function should be monitored regularly